In this issue:
- Cervical Screening Clinical Practice Guidelines
- Association of beta-blockers beyond 1 year after MI and CV outcomes
- CVD risk assessment and reduction: updated NICE guidelines
- Long-term safety of methylphenidate in ADHD
- Interventions to improve uptake of allopurinol for gout
- Aspirin vs clopidogrel after stenting
- Ministry of Health position statement on vaping
- Alert communication: Sodium valproate use in men
- Decision to fund candesartan with hydrochlorothiazide
- Bedaquiline and linezolid to be funded for multi-drug resistant tuberculosis
- Pharmac seeks feedback on biosimilar trastuzumab
- Pharmac confirms funding of rituximab for IgG4-related disease
- Antipsychotic-induced constipation
- Reminder: ACE inhibitor-induced angioedema can be fatal
- Ocular NSAIDs and corneal melting
- SGLT2 inhibitors and potential risk for polycythaemia
- Quarterly summary of recent safety communications
- GP organisations reject funding increase
- New medical devices directorate
- Is regular internet usage protective of dementia in older adults?
Please login below to download this issue (PDF)